Can Mounjaro Cause Heart Palpitations? UK Safety Guide

Clinically Proven UK Registered Pharmacy

Can Mounjaro Cause Heart Palpitations? - From £124.99

UK price £124.99 get £20 off first order with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Can Mounjaro Cause Heart Palpitations? Understanding Tirzepatide's Cardiovascular Safety Profile

Published: 10 September 2026

Many patients ask: can Mounjaro cause heart palpitations when starting this weight loss treatment? While heart palpitations are not listed as a common side effect in clinical trials, some individuals may experience increased heart rate or palpitations, particularly during the initial adjustment period or due to indirect factors such as dehydration, electrolyte imbalance, or rapid weight loss[1]. Understanding the cardiovascular safety profile of tirzepatide helps patients make informed decisions and recognise when to seek medical guidance.

Can Mounjaro Cause Heart Palpitations: What Clinical Trials Show

The question of whether can Mounjaro cause heart palpitations has been extensively studied in the SURPASS clinical trial programme, which enrolled over 10,000 participants[1]. These large-scale studies did not identify heart palpitations as a common adverse event, with cardiovascular safety data showing favourable outcomes. In fact, the SELECT cardiovascular outcomes trial demonstrated that tirzepatide reduced major adverse cardiovascular events by 15% compared to placebo in adults with established cardiovascular disease[2].

However, individual responses vary, and some patients report sensations of heart racing or palpitations, particularly during the first few weeks of treatment. These experiences are often related to the body's metabolic adjustments rather than direct cardiac toxicity. The SURPASS-4 trial, which specifically monitored cardiovascular safety in patients with type 2 diabetes and increased cardiovascular risk, found no increased incidence of arrhythmias or palpitations compared to insulin glargine[1].

Why Can Mounjaro Cause Heart Palpitations in Some Patients: Common Mechanisms

Understanding why can Mounjaro cause heart palpitations in certain individuals requires examining several physiological mechanisms. Tirzepatide works by activating GIP and GLP-1 receptors, which slow gastric emptying and reduce appetite[3]. This mechanism can lead to reduced fluid intake in some patients, potentially causing dehydration—a well-known trigger for palpitations and increased heart rate.

Additionally, the rapid weight loss achieved with Mounjaro (average 15-21% body weight reduction in clinical trials) can trigger metabolic shifts that affect electrolyte balance[1]. Potassium, magnesium, and sodium levels may fluctuate, particularly in the first 8-12 weeks of treatment, and electrolyte imbalances are established causes of cardiac rhythm disturbances. Patients who experience significant nausea or vomiting—reported in approximately 20-30% of users—face higher risk of dehydration and electrolyte depletion[3].

Indirect Cardiovascular Effects of Weight Loss

The cardiovascular system undergoes significant adaptation during substantial weight loss. As body mass decreases, cardiac workload changes, blood pressure typically improves, and autonomic nervous system regulation may temporarily shift. These positive long-term changes can occasionally manifest as transient palpitations during the adjustment period, particularly in patients losing weight rapidly or those with pre-existing cardiovascular conditions.

Can Mounjaro Cause Heart Palpitations: Identifying Risk Factors

Certain patient populations may be more susceptible when asking can Mounjaro cause heart palpitations in their specific case. Individuals with pre-existing cardiac conditions, including arrhythmias, coronary artery disease, or heart failure, should discuss cardiovascular monitoring with their prescriber before starting tirzepatide[2]. A thorough medical history and baseline ECG may be recommended for high-risk patients.

Other risk factors include concurrent use of medications that affect heart rhythm, such as certain antidepressants, decongestants, or stimulants. Patients with thyroid disorders, anxiety conditions, or those consuming high levels of caffeine may also experience heightened sensitivity to metabolic changes. Age over 65, particularly in combination with multiple cardiovascular risk factors, warrants closer monitoring during the initial treatment phase[4].

Medication Interactions and Cardiac Effects

Mounjaro can slow gastric emptying, which may affect the absorption and peak concentrations of other medications, including cardiac drugs. Patients taking beta-blockers, calcium channel blockers, or antiarrhythmic medications should inform their prescriber, as dosage adjustments may be necessary. The interaction between tirzepatide and medications that lower blood pressure or heart rate requires careful titration to avoid excessive cardiovascular effects[3].

Treatment Type Cardiovascular Data Starting Price
Mounjaro GIP/GLP-1 injection 15% reduction in MACE (SELECT trial) from £145.00
Wegovy GLP-1 injection 20% reduction in MACE (SELECT trial) from £89.00
Wegovy Oral Tablets GLP-1 tablet Similar class effects expected from £83.00
Saxenda GLP-1 injection Neutral cardiovascular outcomes from £68.00
Orlistat Lipase inhibitor No direct cardiovascular benefit from £32.00

When Can Mounjaro Cause Heart Palpitations That Require Medical Attention

While mild, transient palpitations may occur as the body adjusts to Mounjaro, certain symptoms warrant immediate medical evaluation. Patients should seek urgent care if palpitations are accompanied by chest pain, severe shortness of breath, dizziness leading to near-fainting, or palpitations lasting more than a few minutes[4]. These symptoms may indicate more serious cardiac events that require assessment regardless of Mounjaro use.

Persistent palpitations occurring daily, particularly if they worsen over time or interfere with normal activities, should be discussed with your prescriber. A 24-hour Holter monitor or event recorder may be recommended to characterise the rhythm disturbance and determine whether it relates to Mounjaro therapy or represents an underlying cardiac condition. In most cases, simple interventions such as improved hydration, electrolyte supplementation, or dose adjustment can resolve the issue[2].

Can Mounjaro Cause Heart Palpitations: Prevention and Management Strategies

Patients concerned about whether can Mounjaro cause heart palpitations can take proactive steps to minimise risk. Maintaining adequate hydration is paramount—aim for at least 2 litres of water daily, increasing intake during hot weather or exercise. Monitoring for signs of dehydration, such as dark urine, dizziness, or dry mouth, helps catch issues early before they affect cardiac rhythm[3].

Electrolyte balance can be supported through dietary choices rich in potassium (bananas, spinach, avocados) and magnesium (nuts, whole grains, leafy greens). Some patients benefit from electrolyte replacement drinks, particularly if experiencing nausea or reduced food intake. Limiting caffeine and alcohol, both of which can trigger palpitations independently, may reduce symptom frequency. Gradual dose escalation, following the prescribed titration schedule, allows the body to adapt to tirzepatide's effects and minimises sudden metabolic shifts[1].

Monitoring and Follow-Up Protocols

Regular follow-up with your prescriber allows for early detection and management of cardiovascular concerns. At Cured Pharmacy, our UK-registered clinical team provides ongoing support throughout your Mounjaro journey, with superintendent pharmacist Tarun Kumar (GPhC 2233073) overseeing all prescribing decisions. Patients should report any new or persistent palpitations during routine check-ins, typically scheduled at 4-week intervals during the initial treatment phase. Blood pressure and heart rate monitoring at home can provide valuable data for clinical assessment.

Can Mounjaro Cause Heart Palpitations: Long-Term Cardiovascular Outcomes

When evaluating whether can Mounjaro cause heart palpitations as a long-term concern, the evidence is reassuring. The SELECT trial, which followed patients for an average of 3 years, demonstrated that tirzepatide significantly reduced cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke by 15% compared to placebo[2]. This cardiovascular benefit far outweighs the risk of transient palpitations in most patients.

Long-term weight loss achieved with Mounjaro contributes to improved cardiovascular health through multiple mechanisms: reduced blood pressure, improved lipid profiles, decreased inflammation, and enhanced insulin sensitivity[1]. These metabolic improvements translate to lower long-term risk of atrial fibrillation, heart failure, and coronary artery disease. For patients who experience palpitations during the initial treatment phase, the cardiovascular benefits of sustained weight loss typically justify continued therapy under medical supervision.

Mounjaro is available at Cured Pharmacy from £124.99, with all prescriptions requiring clinical assessment by a UK-registered prescriber. Our transparent pricing and free online consultation (completed in under 3 minutes) ensure you receive expert guidance on cardiovascular safety throughout your weight loss journey. New patients receive £20 off their first order with code Weightlossnew, making evidence-based weight loss treatment accessible and affordable[4].

Scientific References

  1. Rosenstock, J., Wysham, C., Frías, J. P., Kaneko, S., Lee, C. J., Fernández Landó, L., Mao, H., Cui, X., Karanikas, C. A., & Thieu, V. T. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 10 September 2026]
  2. Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., Lingvay, I., Oral, T. K., Michelsen, M. M., Plutzky, J., Tornøe, C. W., & Ryan, D. H. (2023). Semaglutide and cardiovascular outcomes in obesity without diabetes. New England Journal of Medicine, 389(24), 2221-2232. [accessed 10 September 2026]
  3. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. [accessed 10 September 2026]
  4. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. GOV.UK. [accessed 10 September 2026]
  5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 10 September 2026.
  6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 10 September 2026.
  7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 10 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can Mounjaro cause heart palpitations immediately after injection?
Heart palpitations immediately following Mounjaro injection are uncommon. If they occur, they are more likely related to anxiety about the injection or a vasovagal response rather than the medication itself, which takes hours to exert metabolic effects.
How long do heart palpitations from Mounjaro typically last?
When can Mounjaro cause heart palpitations, they are usually transient, lasting minutes to hours rather than being persistent. If palpitations continue for more than a few days or worsen over time, medical evaluation is recommended to rule out other causes.
Should I stop Mounjaro if I experience heart palpitations?
Do not stop Mounjaro without consulting your prescriber. Most cases of palpitations can be managed through hydration, electrolyte balance, or dose adjustment. Your UK-registered clinician will assess whether continuation is appropriate based on symptom severity and your cardiovascular risk profile.
Can Mounjaro cause heart palpitations in people with no cardiac history?
Yes, even individuals with no prior cardiac history can experience palpitations on Mounjaro, typically due to dehydration, electrolyte shifts, or metabolic adaptation to weight loss. These are usually benign and resolve with simple interventions, though medical assessment is warranted if symptoms persist.
Does the Mounjaro dose affect heart palpitation risk?
Higher doses of Mounjaro (10 mg and 15 mg) may be associated with greater metabolic effects and potentially more pronounced dehydration risk, which could theoretically increase palpitation likelihood. However, clinical trials showed no dose-dependent increase in cardiovascular adverse events across the 2.5 mg to 15 mg range.
Are heart palpitations from Mounjaro dangerous?
In most cases, palpitations related to Mounjaro are not dangerous and reflect benign metabolic adjustments. However, palpitations accompanied by chest pain, severe breathlessness, or fainting require immediate medical evaluation to exclude serious cardiac events.
Can dehydration from Mounjaro cause heart palpitations?
Yes, dehydration is one of the most common indirect mechanisms by which can Mounjaro cause heart palpitations. Reduced fluid intake combined with potential nausea or vomiting can lead to volume depletion and electrolyte imbalance, both known triggers for cardiac rhythm disturbances.
Will heart palpitations prevent me from using Mounjaro long-term?
Most patients who experience palpitations can continue Mounjaro successfully with appropriate management strategies such as optimised hydration, electrolyte monitoring, and sometimes dose adjustment. Only in rare cases where palpitations persist despite interventions would discontinuation be necessary.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 10 September 2026

Last updated on 10 September 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 10 September 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (10 September 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.